Efficacy and safety of combined endoscopic cyanoacrylate injection and balloon-occluded retrograde transvenous occlusion (BRTOcc) of gastrorenal shunts in patients with bleeding gastric fundal varices.
balloon-occluded retrograde transvenous occlusion
cyanoacrylate injection
gastric variceal bleeding
gastric varices
gastrorenal shunt
Journal
Gastroenterology report
ISSN: 2052-0034
Titre abrégé: Gastroenterol Rep (Oxf)
Pays: England
ID NLM: 101620508
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
15
06
2020
revised:
25
07
2020
accepted:
04
08
2020
entrez:
28
7
2021
pubmed:
29
7
2021
medline:
29
7
2021
Statut:
epublish
Résumé
Endoscopic cyanoacrylate (glue) injection of fundal varices may result in life-threatening embolic adverse events through spontaneous gastrorenal shunts (GRSs). Balloon-occluded retrograde transvenous occlusion (BRTOcc) of GRSs during cyanoacrylate injection may prevent serious systemic glue embolization through the shunt. This study aimed to evaluate the efficacy and safety of a combined endoscopic-interventional radiologic (BRTOcc) approach for the treatment of bleeding fundal varices. We retrospectively analysed the data of patients who underwent the combined procedure for acutely bleeding fundal varices between January 2010 and April 2018. Data were extracted for patient demographics, clinical and endoscopic findings, technical details, and adverse events of the endoscopic-BRTOcc approach and patient outcomes. We identified 30 patients (13 [43.3%] women; median age 58 [range, 25-92] years) with gastroesophageal varices type 2 (53.3%, 16/30) and isolated gastric varices type 1 (46.7%, 14/30) per Sarin classification, and median clinical and endoscopic follow-up of 151 (range, 4-2,513) days and 98 (range, 3-2,373) days, respectively. The median volume of octyl-cyanoacrylate: Lipiodol injected was 7 (range, 4-22) mL. Procedure-related adverse events occurred in three (10.0%) patients, including transient fever, non-life-threatening pulmonary glue embolism, and an injection-site ulcer bleed. Complete gastric variceal obturation was achieved in 18 of 21 patients (85.7%) at endoscopic follow-up. Delayed variceal rebleeding was confirmed in one patient (3.3%) and suspected in two patients (6.7%). Although no procedure-related deaths occurred, the overall mortality rate was 46.7%, primarily from liver-disease progression and co-morbidities. The combined endoscopic-BRTOcc procedure is a relatively safe and effective technique for bleeding fundal varices, with a high rate of variceal obturation and a low rate of serious adverse events.
Sections du résumé
BACKGROUND
BACKGROUND
Endoscopic cyanoacrylate (glue) injection of fundal varices may result in life-threatening embolic adverse events through spontaneous gastrorenal shunts (GRSs). Balloon-occluded retrograde transvenous occlusion (BRTOcc) of GRSs during cyanoacrylate injection may prevent serious systemic glue embolization through the shunt. This study aimed to evaluate the efficacy and safety of a combined endoscopic-interventional radiologic (BRTOcc) approach for the treatment of bleeding fundal varices.
METHODS
METHODS
We retrospectively analysed the data of patients who underwent the combined procedure for acutely bleeding fundal varices between January 2010 and April 2018. Data were extracted for patient demographics, clinical and endoscopic findings, technical details, and adverse events of the endoscopic-BRTOcc approach and patient outcomes.
RESULTS
RESULTS
We identified 30 patients (13 [43.3%] women; median age 58 [range, 25-92] years) with gastroesophageal varices type 2 (53.3%, 16/30) and isolated gastric varices type 1 (46.7%, 14/30) per Sarin classification, and median clinical and endoscopic follow-up of 151 (range, 4-2,513) days and 98 (range, 3-2,373) days, respectively. The median volume of octyl-cyanoacrylate: Lipiodol injected was 7 (range, 4-22) mL. Procedure-related adverse events occurred in three (10.0%) patients, including transient fever, non-life-threatening pulmonary glue embolism, and an injection-site ulcer bleed. Complete gastric variceal obturation was achieved in 18 of 21 patients (85.7%) at endoscopic follow-up. Delayed variceal rebleeding was confirmed in one patient (3.3%) and suspected in two patients (6.7%). Although no procedure-related deaths occurred, the overall mortality rate was 46.7%, primarily from liver-disease progression and co-morbidities.
CONCLUSION
CONCLUSIONS
The combined endoscopic-BRTOcc procedure is a relatively safe and effective technique for bleeding fundal varices, with a high rate of variceal obturation and a low rate of serious adverse events.
Identifiants
pubmed: 34316370
doi: 10.1093/gastro/goaa082
pii: goaa082
pmc: PMC8309684
doi:
Types de publication
Journal Article
Langues
eng
Pagination
212-218Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL098967
Pays : United States
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press and Sixth Affiliated Hospital of Sun Yat-sen University.
Références
J Clin Gastroenterol. 2011 Feb;45(2):133-48
pubmed: 21135706
Tech Vasc Interv Radiol. 2013 Jun;16(2):101-51
pubmed: 23830671
Hepatology. 2017 Jan;65(1):310-335
pubmed: 27786365
Rev Med Chil. 2017 Oct;145(10):1336-1341
pubmed: 29488575
Gastrointest Endosc. 2012 Nov;76(5):1064-5
pubmed: 22260886
Gastroenterol Rep (Oxf). 2019 Sep 17;7(6):403-410
pubmed: 31857902
Semin Intervent Radiol. 2018 Aug;35(3):169-184
pubmed: 30087520
Liver Int. 2020 Nov;40(11):2602-2611
pubmed: 32901449
Hepatology. 1992 Dec;16(6):1343-9
pubmed: 1446890
Minim Invasive Ther Allied Technol. 2016 Dec;25(6):337-344
pubmed: 27309571
J Gastroenterol Hepatol. 1996 Jan;11(1):51-8
pubmed: 8672742
J Hepatol. 2015 Sep;63(3):743-52
pubmed: 26047908
Clin Transl Gastroenterol. 2014 Oct 02;5:e61
pubmed: 25273155
Gastrointest Endosc. 2016 Jun;83(6):1164-72
pubmed: 26452992
Biomed Res Int. 2019 Apr 3;2019:2674758
pubmed: 31073523
Gastroenterol Rep (Oxf). 2019 Feb;7(1):13-23
pubmed: 30792862
J Clin Gastroenterol. 2001 Jul;33(1):49-52
pubmed: 11418791
Endoscopy. 1986 Jan;18(1):25-6
pubmed: 3512261
Neurogastroenterol Motil. 2017 Nov;29(11):
pubmed: 28580600
Pancreatology. 2018 Oct;18(7):691-699
pubmed: 30061072
J Clin Gastroenterol. 2020 Aug;54(7):655-660
pubmed: 31688366
Aliment Pharmacol Ther. 2017 Nov;46(9):790-799
pubmed: 28869287
Medicine (Baltimore). 2015 Oct;94(41):e1725
pubmed: 26469912
BMJ Open Gastroenterol. 2018 Jun 6;5(1):e000204
pubmed: 29915665
BMJ Evid Based Med. 2018 Apr;23(2):60-63
pubmed: 29420178
Am J Gastroenterol. 2002 Apr;97(4):1010-5
pubmed: 12003381
Clin Gastroenterol Hepatol. 2019 Jan;17(1):54-64.e1
pubmed: 30196155
Gastrointest Endosc. 2013 Nov;78(5):711-21
pubmed: 23891417
Liver Int. 2018 Nov;38(11):1965-1973
pubmed: 29675889
Gastroenterol Rep (Oxf). 2017 Aug;5(3):178-184
pubmed: 28852522